Jalali Hossein, Mahdavi Mohammad Reza, Roshan Payam, Kosaryan Mehrnoush, Karami Hosein, Mahdavi Mehrad
Hematology. 2014 Jun;19(4):192-5. doi: 10.1179/1607845413Y.0000000115. Epub 2013 Nov 25.
Alpha thalassemia is one of the most prevalent disorders worldwide and carrier frequency of the disease is varied in different parts of the world. Although different studies in Iran and Mazandaran province have been carried out to identify different mutations of alpha globin gene among people with low hematological indices, frequencies of these mutations were unknown in general population, and thus the aim of this study was to evaluate the carrier frequencies of alpha globin gene mutations among neonates in Mazandaran.
Four hundred and twelve neonates were collected from a delivery ward of a hospital in Sari. DNA was extracted from their cord blood samples using phenol-chloroform-based method. For the detection of five common alpha thalassemia gene mutations, multiplex-GAP-PCR and PCR-RFLP methods were applied.
Sixty three (15.29%, confidence interval, CI 95%: 11.81-18.77) of investigated neonates had at least one of the five evaluated mutations. The -α(3.7) deletion had the highest frequency (9.7%, CI 95%: 6.84-12.56) and none of the neonates had -(Med) double gene deletion. The -α(4.2) deletion, ααα(anti3.7) triplication, and α(-5nt) mutations had frequencies of 4.1% (CI 95%: 2.19-36.01), 2.2% (CI 95%: 0.78-3.62), and 0.49% (CI 95%: -0.18-1.16), respectively.
Our study showed that in most of the alpha thalassemia carriers just one copy of alpha globin gene was absent and they are not at risk of having children with Hb H disease or hydrops fetalis; however, up to 2.2% of neonates were carriers for ααα(anti3.7) triplication and they will be at risk for having a child with thalassemia intermediate if they marry a person which is a carrier of beta thalassemia.
α地中海贫血是全球最常见的疾病之一,其携带者频率在世界不同地区有所差异。尽管伊朗和马赞德兰省已开展不同研究以确定血液学指标较低人群中α珠蛋白基因的不同突变,但这些突变在普通人群中的频率尚不清楚,因此本研究旨在评估马赞德兰新生儿中α珠蛋白基因突变的携带者频率。
从萨里一家医院的产房收集了412名新生儿。使用基于酚 - 氯仿的方法从他们的脐带血样本中提取DNA。为检测五种常见的α地中海贫血基因突变,应用了多重间隙聚合酶链反应(multiplex - GAP - PCR)和聚合酶链反应 - 限制性片段长度多态性(PCR - RFLP)方法。
63名(15.29%,置信区间,CI 95%:11.81 - 18.77)被调查的新生儿至少有五种评估突变中的一种。-α(3.7)缺失频率最高(9.7%,CI 95%:6.84 - 12.56),且没有新生儿有-(Med)双基因缺失。-α(4.2)缺失、ααα(anti3.7)三联体和α(-5nt)突变的频率分别为4.1%(CI 95%:2.19 - 36.01)、2.2%(CI 95%:0.78 - 3.62)和0.49%(CI 95%:-0.18 - 1.16)。
我们的研究表明,大多数α地中海贫血携带者仅缺失一份α珠蛋白基因,他们没有生育患血红蛋白H病或胎儿水肿患儿的风险;然而,高达2.2%的新生儿是ααα(anti3.7)三联体的携带者,如果他们与β地中海贫血携带者结婚,将有生育中间型地中海贫血患儿的风险。